# Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

> **NCT00308711** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 1308 (actual)

## Conditions studied

- Cervical Ripening
- Labor, Induced

## Interventions

- **DRUG:** Misoprostol vaginal insert 100 mcg
- **DRUG:** Misoprostol vaginal insert 50 mcg
- **DRUG:** Dinoprostone vaginal insert (Cervidil)

## Key facts

- **NCT ID:** NCT00308711
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 1308 (ACTUAL)
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308711, "Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00308711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*